These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17284325)

  • 1. Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice.
    Hasegawa H; Inoue A; Muraoka M; Yamanouchi J; Miyazaki T; Yasukawa M
    Arthritis Res Ther; 2007; 9(1):R15. PubMed ID: 17284325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
    Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
    Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.
    Hasegawa H; Inoue A; Kohno M; Muraoka M; Miyazaki T; Terada M; Nakayama T; Yoshie O; Nose M; Yasukawa M
    Arthritis Rheum; 2006 Apr; 54(4):1174-83. PubMed ID: 16575871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
    Saito K; Mori S; Date F; Ono M
    Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu.
    Divekar AA; Dubey S; Gangalum PR; Singh RR
    J Immunol; 2011 Jan; 186(2):924-30. PubMed ID: 21149603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.
    Koga T; Mizui M; Yoshida N; Otomo K; Lieberman LA; Crispín JC; Tsokos GC
    Autoimmunity; 2014 Nov; 47(7):445-50. PubMed ID: 24829059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential.
    Fu S; Yopp AC; Mao X; Chen D; Zhang N; Chen D; Mao M; Ding Y; Bromberg JS
    Am J Transplant; 2004 Jan; 4(1):65-78. PubMed ID: 14678036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
    Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M
    Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
    Yang CH; Tian L; Ling GS; Trendell-Smith NJ; Ma L; Lo CK; Stott DI; Liew FY; Huang FP
    Eur J Immunol; 2008 Jun; 38(6):1664-76. PubMed ID: 18465774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB.
    Saito K; Mori S; Date F; Hong G
    Autoimmunity; 2015; 48(6):379-88. PubMed ID: 25847253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKG2D
    Yang D; Tian Z; Zhang M; Yang W; Tang J; Wu Y; Ni B
    Sci Rep; 2017 Apr; 7(1):1288. PubMed ID: 28455530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice.
    Hayashi Y; Haneji N; Hamano H
    Pathol Int; 1994 Aug; 44(8):559-68. PubMed ID: 7952145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice.
    Kulkarni O; Eulberg D; Selve N; Zöllner S; Allam R; Pawar RD; Pfeiffer S; Segerer S; Klussmann S; Anders HJ
    J Pharmacol Exp Ther; 2009 Feb; 328(2):371-7. PubMed ID: 18997060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Akpek EK; Jabs DA; Gérard HC; Prendergast RA; Hudson AP; Lee B; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):185-90. PubMed ID: 14691172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sialadenitis after cellular transfer in autoimmune MRL/lpr mice.
    Skarstein K; Johannessen AC; Holmdahl R; Jonsson R
    Clin Immunol Immunopathol; 1997 Aug; 84(2):177-84. PubMed ID: 9245550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin gallate inhibits oxidative stress-induced DNA damage and apoptosis in MRL-Fas(lpr) mice with autoimmune sialadenitis via upregulation of heme oxygenase-1 and Bcl-2.
    Saito K; Mori S; Date F; Ono M
    Autoimmunity; 2014 Feb; 47(1):13-22. PubMed ID: 24392721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
    Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
    J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.